Following the science to develop and evaluate potential innovative treatment options to help people living with rare cardiology conditions.
We are following the science to develop and evaluate innovative treatment options to help address the unmet need of people living with rare cardiology conditions.
The survival and quality of life for people affected by these conditions are severely reduced and affected, respectively.1-3 Through internal innovations and external collaborations, we are exploring diverse and complementary modalities to address significant unmet medical needs.
Combining AstraZeneca's expertise in cardiology with our leadership in rare disease, we are positioned to lead and develop therapeutic and diagnostic advances to help address the spectrum of needs for people living with rare cardiology conditions.
Researching and developing innovative treatments that aim to target the underlying causes of rare bone disorders.
Identifying potential new opportunities to advance care for those impacted by rare endocrine diseases.
Working to improve potential outcomes for more people living with rare hematological diseases worldwide.
Enhancing the understanding of rare renal diseases and accelerating
the development of potential therapies.
Striving to advance scientific understanding in rare neurology and to accelerate the development of potential life-changing treatments.
Striving to advance scientific understanding of rare cancers to bring
new solutions.